| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Stroke. 1999;30:414-418.)
© 1999 American Heart Association, Inc.
Original Contributions |
From the Department of Neurology, Kurume University Medical Center (Y.S., M.K.), and the First Department of Internal Medicine, Kurume University School of Medicine (T.T., K.O.), Kurume, Japan.
Correspondence to Dr Yoshihiro Sato, Department of Neurology, Kurume University Medical Center, 155-1 Kokubu-machi, Kurume 839-0863, Japan. E-mail y-sato{at}ktarn.or.jp
| Abstract |
|---|
|
|
|---|
MethodsWe measured bilaterally sensory nerve conduction velocity
(SNCV), motor nerve conduction velocity (MNCV), sensory nerve action
potentials (SNAP) at the wrist, palm-to-wrist distal sensory latency
(DSL), palm-to-wrist SNAP, compound motor action potentials (CMAP), and
distal motor latency (DML) in stroke patients and control subjects.
Controls were right-handed,
65 years old, lucid, independent in their
activities of daily living, and had no disease known to cause CTS.
Stroke patients were divided into a functioning hand group (n=61) and a
disused hand group (n=71). All patients had hemiplegia.
ResultsTinel's sign was observed on the nonparetic side in 57.7% of patients with a disused hand and in 31.1% of those with a functioning hand. All electrophysiological indices were significantly more abnormal on the nonparetic side than on the hemiparetic side or in controls. Patients with a disused hand showed greater abnormality on the nonparetic side in SNCV, SNAP, palm-to-wrist DSL, DML, and CMAP than patients with a functioning hand.
ConclusionsOveruse of the nonparetic hand and wrist of the nonparetic side may result in CTS in stroke patients, especially when the paretic hand is not functional. Wrist splinting or other prophylactic treatments beginning soon after stroke might help to prevent CTS.
Key Words: electrophysiology hemiplegia median nerve stroke
| Introduction |
|---|
|
|
|---|
| Subjects and Methods |
|---|
|
|
|---|
Comparison Group
The comparison group was composed of men and women who were
right-handed,
65 years old, lucid, independent in their activities of
daily living; who had no disease known to cause CTS, no history of
frequent, repetitive use of the hand or wrist; and who lacked any upper
extremity neurological deficit. The subjects were volunteers drawn from
the community, matched by age and sex with the hemiparetic subjects.
Fifty-six control subjects with no conditions affecting
peripheral nerve evaluation were selected for study.
Neurological Examination of the Median Nerve on the Unaffected
Side
Neurological examinations were performed to evaluate the degree
or intensity of the following symptoms and signs of CTS in the
unaffected hand and wrist: dysesthesia (numbness, tingling, and pain)
in the hand; paresthesias and decreased sensation in the median nerve
distribution; dry skin or a color change visible over the palm; thenar
muscle atrophy; and Tinel's and Phalen's signs.
Sensory and Motor Nerve Conduction
Sensory nerve conduction velocity (SNCV) and motor nerve
conduction velocity (MNCV) were measured with a Neuropack 2 instrument
(Nihon Kohden) in an air-conditioned room at 23°C to 25°C.
Skin surface temperature was maintained at 34°C. Median and ulnar
nerve conduction studies were performed bilaterally in all subjects.
Antidromic sensory responses from the median and ulnar nerve were
measured. Ring electrodes were placed on digits II or V, respectively,
and SNCV was calculated in both nerves between the wrist and digit II
or the wrist and digit V by determining the onset of sensory nerve
action potentials (SNAP). Median nerve SNAP were recorded across
the wrist with the active recording electrode 14 cm from the
stimulator cathode.10 In addition, median sensory
conduction from the palm to the wrist was measured over a 7-cm
conduction distance.11 Distal sensory latency (DSL) and
SNAP at the palm were recorded in the same manner. The voltage used
for stimulation was increased until the SNAP reached maximal amplitude
in both techniques for median nerve sensory assessment.
MNCV was determined in both median nerves by stimulation at the wrist. Median nerve compound motor action potential (CMAP) and distal motor latency (DML) were measured with the stimulating and recording cathodes 8 cm apart. No needle examination was performed. All patients and volunteers were informed of the nature of the study before witnessed consent was obtained from each participant.
Data Analysis
Data are expressed as mean±SD. Group differences involving
categorical data were tested by
2
analyses. The differences in
electrophysiological indices between the
left and right sides in control subjects and between the affected and
unaffected sides in patients were assessed by paired t
tests. Student's t test was used to assess differences in
electrophysiological parameters
between controls and patients. Because a subclinical compression
neuropathy is common in elderly subjects such as the
controls in our study, means of
electrophysiological indices on the left
and right side were calculated for use as control values. Then 1-way
ANOVA and Fisher's protected least significant difference test were
used to assess electrophysiological
differences among mean values for control, functioning, and disused
hands. In performing electrodiagnostic assessment for CTS,
we used parametric analyses to define the normal range
statistically as values within 2 SD of the mean, assuming a normal
distribution in the control population.12 This
definition took account of the fact that subclinical CTS exists to a
varying extent in the general population. Because a normal distribution
in controls was confirmed beforehand, the nerve conduction study was
considered to support an
electrophysiological diagnosis of CTS when
each index was significantly reduced or delayed at least 2 SD below or
above the control mean.
| Results |
|---|
|
|
|---|
|
Symptom and Signs of Carpal Tunnel Syndrome on the Unaffected
Side
Dysesthesias were not observed in any patient. As shown in Table 2
, paresthesia, dry skin, color change,
or mild thenar muscle atrophy occasionally was observed contralaterally
to a paretic but functioning or disused hand. No significant difference
was seen between functioning and disused groups in the prevalence of
these signs. Mildly decreased sensation was observed in a median nerve
distribution in 19 patients, more frequently in the disused hand group
than in the functioning hand group. Notably, Tinel's sign was
significantly more prevalent in the disused hand group (57.7%) than in
the functioning hand group (31.1%).
|
Sensory and Motor Conduction in the Median Nerve
For electrophysiological indices
measured separately on the left and right in controls, left and right
sides were averaged and the mean was used as the control value (see
Table 3
). In control subjects,
only slight and insignificant differences were observed in
electrophysiological indices between left
and right sides. SNCV, DSL from the palm to the wrist, MNCV, and DML
for the median nerve on the unaffected side in stroke patients were
significantly prolonged compared with the hemiparetic side and the
controls. Also, in stroke patients, SNAP, SNAP from the palm to the
wrist, and median nerve CMAP were significantly reduced on the
unaffected side versus amplitudes on the hemiparetic side and in
controls.
|
SNCV, DML, and CMAP were slower or reduced in the disused hand group than in the functioning hand group, although the differences were not statistically significant. In both groups, however, these indices were significantly slower or reduced relative to those in controls. SNAP and SNAP from the palm to the wrist were significantly reduced in the disused hand group compared with controls; no significant changes in SNAP or SNAP from the palm to the wrist were observed between the functioning hand and control groups. DSL from the palm to the wrist was significantly slower in the disused hand group than in both the functioning hand and control groups.
The percentage of cases 2 SD below or beyond the control mean was
higher in the disused hand group than in the functioning hand group for
all electrophysiological indices except for
MNCV and CMAP. The highest occurrence of abnormal values was 62%, for
the distal latency from the palm to the wrist in the disused hand
group, followed by 41% for the DML in the disused hand group (Table 4
).
|
Gender and Sidedness
CTS generally occurs more frequently in women than in men, and in
both genders the dominant hand is more likely to be affected than the
nondominant hand.13 However, no significant gender-related
differences and no side-to-side differences in patients were seen for
any electrophysiological
parameter (data not shown).
Mobility With and Without Assist Devices
No significant differences in the 7
electrophysiological indices were seen
between patients using and not using assist devices for ambulation,
except for DSL from the palm to the wrist, which showed a significant
delay in the device-using group compared with the no-device group
(2.184±1.033 versus 1.934±0.341, P=0.0365). No significant
differences in the occurrence of neurological symptoms and signs
indicative of CTS were seen between device and nondevice groups (data
not shown).
| Discussion |
|---|
|
|
|---|
The prevalence of CTS in the general population has been reported to be 125 to 220 per 100 000.8 Repetitive use of the hand or wrist is a common cause of CTS.4 5 6 7 8 The mechanism involves increased pressure within the carpal canal due to nonspecific flexor tenosynovitis.8 Stroke patients with disuse of a hand may overuse their unaffected hand, particularly when assistive devices are used for mobility. In this study we expected that patients using assist devices would have more overuse of the hand than those not using a device, but 6 of 7 electrophysiological parameters did not differ significantly between device users and nonusers. However, palm-to-wrist DSL was more abnormal in the disused hand group than in the functioning hand group; a higher percentage of patients with a disused hand deviated >2 SD from control means for the indices than when patients had a functioning hand. Therefore, the determinant of CTS on the unaffected side is not use of an assist device but functional severity of palsy of the opposite hand.
Sensory fibers constitute 94% of median nerve fibers15 and are the first to be affected by compression in the carpal tunnel. Not only sensory parameters such as SNCV, SNAP, or DSL from the palm to the wrist but also motor parameters showed involvement, as evidenced by prolonged DML or reduced CMAP in both functioning and disused hand groups. This implies that continuing repetitive use of the unaffected hand results in involvement of both sensory and motor fibers of the median nerve.
Significant deficits in the unaffected hand of hemiparetic stroke patients compared with normal subjects have been reported with regard to grip strength, flexion of fingers and thumb, pinch strength, kinesthesia for the thumb, gross manual dexterity, fine manual dexterity, and motor coordination.1 2 3 We believe that CTS represents 1 cause of these symptoms, because "centric" sensory deficits such as s kinesthesia may be seen in CTS.16
To prevent CTS on the intact side in patients after stroke, wrist splints17 or administration of nonsteroidal anti-inflammatory drugs16 or possibly vitamin B618 may prove useful if such treatment is begun soon after stroke. If definite symptomatic CTS occurs in patients such as the 3 who were the index cases for the present study, surgical therapy19 should be considered preferable to local steroid injections20 or short-term treatment with oral prednisone21 because such conservative therapy cannot prevent progression of thenar muscle atrophy.
Received September 29, 1998; revision received November 16, 1998; accepted November 24, 1998.
| References |
|---|
|
|
|---|
2. Smutok MA, Grafman G, Salazar AM, Sweeney JK, Jonas BS, DiRocco PJ. Effects of unilateral brain damage on contralateral side and ipsilateral upper extremity function in hemiplegia. Phys Ther. 1989;69:195203.
3.
Desrosiers J, Bourbonnalis D, Bravo G, Roy PM, Guay M.
Performance of the "unaffected" upper extremity of elderly
stroke patients. Stroke. 1996;27:15641570.
4. Cannon L, Bernnacki E, Walter S. Personal and occupational factors associated with carpal tunnel syndrome. J Occup Med. 1981;23;255258.
5. Masear VR, Hayes JM, Hyde AG. An industrial cause of carpal tunnel syndrome. J Hand Surg (Am). 1986;11:222227.[Medline] [Order article via Infotrieve]
6. Silverstein BA, Fine LJ, Armstrong TJ. Occupational factors and carpal tunnel syndrome. Am J Ind Med. 1987;11:343358.[Medline] [Order article via Infotrieve]
7.
Franklin GM, Haug J, Heyer N, Checkoway H, Peck N.
Occupational carpal tunnel syndrome in Washington state, 19841988.
Am J Public Health. 1991;81:741746.
8. Dawson MW. Entrapment neuropathies of the upper extremities. N Engl J Med. 1993;20132018.
9.
Scandinavian Stroke Study Group. Multicenter trial of
hemodilution in ischemic stroke: background and study protocol.
Stroke. 1985;16:885890.
10. Dibenedetto M, Mitz M, Klingbell G, Davidoff DD. New criteria for sensory nerve conduction especially using in diagnosing carpal tunnel syndrome. Arch Phys Med Rehab. 1986;67:586589.[Medline] [Order article via Infotrieve]
11. Jackson D, Clifford JC. Electrodiagnosis of mild carpal tunnel syndrome. Arch Phys Med Rehab. 1989;70:199204.[Medline] [Order article via Infotrieve]
12. Salerno DF, Franzblau A, Werner RA, Bromberg MB, Armstrong TJ, Albers JW. Median and ulnar nerve conduction studies among workers: normative value. Muscle Nerve. 1998;21:9991005.[Medline] [Order article via Infotrieve]
13. Nathan PA, Keniston RC, Myers LD, Meadows KD, Lockwood RS. Natural history of median nerve sensory conduction in industry: relationship to symptoms and carpal tunnel syndrome in 558 hands over 11 years. Muscle Nerve. 1998;21:711721.[Medline] [Order article via Infotrieve]
14. Buchthal F, Rosenfalk A. Evoked action potentials and conduction velocity in human sensory nerves. Brain Res. 1966;3:122.
15. Omer G. Median nerve compression at the wrist. Hand Clin. 1992;8:317324.[Medline] [Order article via Infotrieve]
16.
Report of the Quality Standards Subcommittee of the
American Academy of Neurology. Practice parameter for
carpal tunnel syndrome. Neurology. 1993;43:24062409.
Summary statement.
17. Kruger VL, Kraft GH, Deitz JC, Ameis A, Polissar L. Carpal tunnel syndrome: objective measures and splint use. Arch Phys Med Rehab. 1991;72:517520.[Medline] [Order article via Infotrieve]
18. Ellis JM. Treatment of carpal tunnel syndrome with vitamin B6. South Med J. 1987;80:882884.[Medline] [Order article via Infotrieve]
19. Harter BT Jr, McKiernan JE Jr, Kirzinger SS, Archer FW, Peters CK, Harter KC. Carpal tunnel syndrome: surgical and nonsurgical treatment. J Hand Surg (Am). 1993;18:734739.[Medline] [Order article via Infotrieve]
20. Giannini F, Passero S, Cioni R. Electrophysiologic evaluation of local steroid injection in carpal tunnel syndrome. Arch Phys Med Rehabil. 1991;72:738742.[Medline] [Order article via Infotrieve]
21.
Chang MH, Chiang HT, Lee SSJ, Ger LP, Lo YK. Oral drug
in carpal tunnel syndrome. Neurology. 1998;51:390393.
This article has been cited by other articles:
![]() |
N. Bonifer and K. M Anderson Application of Constraint-Induced Movement Therapy for an Individual With Severe Chronic Upper-Extremity Hemiplegia Physical Therapy, April 1, 2003; 83(4): 384 - 398. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Stroke Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1999 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |